Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186876073> ?p ?o ?g. }
- W3186876073 endingPage "239" @default.
- W3186876073 startingPage "232" @default.
- W3186876073 abstract "To study the effect of interferon-α2 auto-antibodies (IFN-α2 Abs) on clinical and virological outcomes in critically ill COVID-19 patients and the risk of IFN-α2 Abs transfer during convalescent plasma treatment.Sera from healthy controls, cases of COVID-19, and other respiratory illness were tested for IFN-α2 Abs by ELISA and a pseudo virus-based neutralization assay. The effects of disease severity, sex, and age on the risk of having neutralizing IFN-α2 Abs were determined. Longitudinal analyses were performed to determine association between IFN-α2 Abs and survival and viral load and whether serum IFN-α2 Abs appeared after convalescent plasma transfusion.IFN-α2 neutralizing sera were found only in COVID-19 patients, with proportions increasing with disease severity and age. In the acute stage of COVID-19, all sera from patients with ELISA-detected IFN-α2 Abs (13/164, 7.9%) neutralized levels of IFN-α2 exceeding physiological concentrations found in human plasma and this was associated with delayed viral clearance. Convalescent plasma donors that were anti-IFN-α2 ELISA positive (3/118, 2.5%) did not neutralize the same levels of IFN-α2. Neutralizing serum IFN-α2 Abs were associated with delayed viral clearance from the respiratory tract.IFN-α2 Abs were detected by ELISA and neutralization assay in COVID-19 patients, but not in ICU patients with other respiratory illnesses. The presence of neutralizing IFN-α2 Abs in critically ill COVID-19 is associated with delayed viral clearance. IFN-α2 Abs in COVID-19 convalescent plasma donors were not neutralizing in the conditions tested." @default.
- W3186876073 created "2021-08-02" @default.
- W3186876073 creator A5002777079 @default.
- W3186876073 creator A5004691327 @default.
- W3186876073 creator A5008677339 @default.
- W3186876073 creator A5018908632 @default.
- W3186876073 creator A5026174661 @default.
- W3186876073 creator A5031464170 @default.
- W3186876073 creator A5035545520 @default.
- W3186876073 creator A5037034052 @default.
- W3186876073 creator A5038465935 @default.
- W3186876073 creator A5048764247 @default.
- W3186876073 creator A5051577519 @default.
- W3186876073 creator A5056575262 @default.
- W3186876073 creator A5062100479 @default.
- W3186876073 creator A5066941440 @default.
- W3186876073 creator A5078922736 @default.
- W3186876073 date "2021-11-12" @default.
- W3186876073 modified "2023-10-16" @default.
- W3186876073 title "Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19" @default.
- W3186876073 cites W1970700139 @default.
- W3186876073 cites W2041359053 @default.
- W3186876073 cites W3001118548 @default.
- W3186876073 cites W3014721277 @default.
- W3186876073 cites W3017110669 @default.
- W3186876073 cites W3022564719 @default.
- W3186876073 cites W3028583791 @default.
- W3186876073 cites W3034858522 @default.
- W3186876073 cites W3039328844 @default.
- W3186876073 cites W3041960835 @default.
- W3186876073 cites W3087862874 @default.
- W3186876073 cites W3088256443 @default.
- W3186876073 cites W3096658347 @default.
- W3186876073 cites W3110542218 @default.
- W3186876073 cites W3111431752 @default.
- W3186876073 cites W3112385563 @default.
- W3186876073 cites W3118947400 @default.
- W3186876073 cites W3127394181 @default.
- W3186876073 cites W3151199527 @default.
- W3186876073 cites W3162684874 @default.
- W3186876073 cites W3175047617 @default.
- W3186876073 cites W3195130348 @default.
- W3186876073 cites W4237671905 @default.
- W3186876073 doi "https://doi.org/10.1007/s10875-021-01168-3" @default.
- W3186876073 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8586830" @default.
- W3186876073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34767118" @default.
- W3186876073 hasPublicationYear "2021" @default.
- W3186876073 type Work @default.
- W3186876073 sameAs 3186876073 @default.
- W3186876073 citedByCount "22" @default.
- W3186876073 countsByYear W31868760732022 @default.
- W3186876073 countsByYear W31868760732023 @default.
- W3186876073 crossrefType "journal-article" @default.
- W3186876073 hasAuthorship W3186876073A5002777079 @default.
- W3186876073 hasAuthorship W3186876073A5004691327 @default.
- W3186876073 hasAuthorship W3186876073A5008677339 @default.
- W3186876073 hasAuthorship W3186876073A5018908632 @default.
- W3186876073 hasAuthorship W3186876073A5026174661 @default.
- W3186876073 hasAuthorship W3186876073A5031464170 @default.
- W3186876073 hasAuthorship W3186876073A5035545520 @default.
- W3186876073 hasAuthorship W3186876073A5037034052 @default.
- W3186876073 hasAuthorship W3186876073A5038465935 @default.
- W3186876073 hasAuthorship W3186876073A5048764247 @default.
- W3186876073 hasAuthorship W3186876073A5051577519 @default.
- W3186876073 hasAuthorship W3186876073A5056575262 @default.
- W3186876073 hasAuthorship W3186876073A5062100479 @default.
- W3186876073 hasAuthorship W3186876073A5066941440 @default.
- W3186876073 hasAuthorship W3186876073A5078922736 @default.
- W3186876073 hasBestOaLocation W31868760731 @default.
- W3186876073 hasConcept C126322002 @default.
- W3186876073 hasConcept C14086860 @default.
- W3186876073 hasConcept C142462285 @default.
- W3186876073 hasConcept C159047783 @default.
- W3186876073 hasConcept C159654299 @default.
- W3186876073 hasConcept C190139176 @default.
- W3186876073 hasConcept C203014093 @default.
- W3186876073 hasConcept C2522874641 @default.
- W3186876073 hasConcept C2776178377 @default.
- W3186876073 hasConcept C2777945365 @default.
- W3186876073 hasConcept C2779134260 @default.
- W3186876073 hasConcept C2779261636 @default.
- W3186876073 hasConcept C3008058167 @default.
- W3186876073 hasConcept C3018027319 @default.
- W3186876073 hasConcept C524204448 @default.
- W3186876073 hasConcept C534529494 @default.
- W3186876073 hasConcept C71924100 @default.
- W3186876073 hasConceptScore W3186876073C126322002 @default.
- W3186876073 hasConceptScore W3186876073C14086860 @default.
- W3186876073 hasConceptScore W3186876073C142462285 @default.
- W3186876073 hasConceptScore W3186876073C159047783 @default.
- W3186876073 hasConceptScore W3186876073C159654299 @default.
- W3186876073 hasConceptScore W3186876073C190139176 @default.
- W3186876073 hasConceptScore W3186876073C203014093 @default.
- W3186876073 hasConceptScore W3186876073C2522874641 @default.
- W3186876073 hasConceptScore W3186876073C2776178377 @default.
- W3186876073 hasConceptScore W3186876073C2777945365 @default.
- W3186876073 hasConceptScore W3186876073C2779134260 @default.
- W3186876073 hasConceptScore W3186876073C2779261636 @default.